文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

孕妇与新发传染病疫苗:防范、研究与应对的伦理指南

Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response.
PubMed 文献 · Vaccine · 2019-05-03

该指南由PREVENT工作组(17名多学科国际专家)制定,针对孕妇及其后代在疫苗研究中被排除的问题,提出22条具体建议,以伦理上负责任、社会公正且尊重的方式,将孕妇利益纳入新发病原体疫苗的研发与部署。

要点

  • 孕妇及其后代在疫苗研究中长期被排除,导致疫情应对中疫苗覆盖不公。
  • 指南提出22条建议,推动孕妇公平纳入疫苗准备、研发与接种。
  • 需在公共卫生准备、疫苗研发和接种方式上采取新方法。

核心结论

  • 为确保孕妇及其后代的需求得到公平对待,需在公共卫生准备、疫苗研发和疫苗接种方面采取新方法。

研究设计与样本

  • 指南由PREVENT工作组制定,该工作组由17名专注于生物伦理学、母体免疫、母胎医学、产科、儿科、哲学、公共卫生及疫苗研究与政策的多学科国际专家组成,并咨询了各类外部专家和利益相关者。

主要发现

  • 寨卡病毒、流感和埃博拉病毒暴发凸显了传染病疫情可严重且有时独特地影响孕妇及其后代的健康利益。
  • 历史上,孕妇及其后代在很大程度上被排除在针对流行病威胁的疫苗研究议程和投资策略之外,这可能导致在疫情暴发期间被排除在未来的疫苗接种活动之外。
  • 这种情况对孕妇及其后代极为不公,从公共卫生角度看也存在严重问题。

关键数值与推荐

  • 该指南提出了22条具体建议,为以伦理上负责任、社会公正且尊重的方式将孕妇利益纳入新发病原体疫苗的开发和部署提供了路线图。

临床怎么用

  • 在疫苗研发和部署中,应主动考虑孕妇及其后代的利益,确保其公平纳入疫苗研究和接种活动。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Zika virus, influenza, and Ebola have called attention to the ways in which infectious disease outbreaks can severely - and at times uniquely - affect the health interests of pregnant women and their offspring. These examples also highlight the critical need to proactively consider pregnant women and their offspring in vaccine research and response efforts to combat emerging and re-emerging infectious diseases. Historically, pregnant women and their offspring have been largely excluded from research agendas and investment strategies for vaccines against epidemic threats, which in turn can lead to exclusion from future vaccine campaigns amidst outbreaks. This state of affairs is profoundly unjust to pregnant women and their offspring, and deeply problematic from the standpoint of public health. To ensure that the needs of pregnant women and their offspring are fairly addressed, new approaches to public health preparedness, vaccine research and development, and vaccine delivery are required. This Guidance offers 22 concrete recommendations that provide a roadmap for the ethically responsible, socially just, and respectful inclusion of the interests of pregnant women in the development and deployment of vaccines against emerging pathogens. The Guidance was developed by the Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT) Working Group - a multidisciplinary, international team of 17 experts specializing in bioethics, maternal immunization, maternal-fetal medicine, obstetrics, pediatrics, philosophy, public health, and vaccine research and policy - in consultation with a variety of external experts and stakeholders.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Krubiner CB, Faden RR, Karron RA, et al. Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response. Vaccine. 2019. PMID: 31060949. doi:10.1016/j.vaccine.2019.01.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。